mlsanityData to 14 Oct 2026

A Guide to Estimating Conditional Average Treatment Effects in Competing Risks Settings

arXiv 2606.18281 ↗First posted 8 Jun 2026stat.AP cs.LG stat.MLcited by 0

Not on the map. Why?

Abstract (arXiv)

Conditional average treatment effects (CATEs) are central to treatment decision-making in personalized medicine. In competing risks settings, estimating CATEs from survival data allows for patient-specific assessments of treatment effectiveness for a specific event of interest while properly accounting for alternative event types. This distinction is essential in the presence of comorbidities, where competing causes of death may otherwise confound the therapeutic benefit. Focusing on right-censored survival times with binary treatment, we examine CATEs defined as covariate-conditional differences in the absolute risk for the event of interest at a fixed time. To this end, we study meta-learners which adapt machine learning algorithms for CATE estimation in competing risks scenarios. We systematically compare six meta-learners, combining Cox regression or random survival forests for risk modeling with elastic net regression or random forests for direct CATE modeling. To provide practical guidance on model selection, we evaluate their performance in multiple simulation settings, that differ in hazard complexity, treatment heterogeneity, treatment assignment, event type distribution and censoring. To facilitate applied use, we provide the R package, crsurvlearners, which implements all considered approaches.

Key facts. No citing papers in the map yet (data through 14 Oct 2026). Builds on 3 of its 85 references that are in the map. First posted on arXiv 8 Jun 2026.

Builds on

3 of 85 references.

References · 3

  1. 2022Estimating individual treatment effects under unobserved confounding using binary instrumentscited by 18
  2. 2023Improving Precision of RCT-Based CATE Estimation using Data Borrowing with Double Calibrationcited by 4
  3. 2024Doubly Robust Targeted Estimation of Subgroup Average Treatment Effects for Time-to-event Outcomes with Competing Riskscited by 1

Built on by

Not cited yet.